Jillian Baron is an Infectious Disease physician affiliated with Hospital of the University of Pennsylvania. OpenAlex indexes 9 publications with 287 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
71.5%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor30.2%Dovato42%Cabenuva28%Tivicay22%Juluca8%Part D<11 patientsShort-acting sulfonamides11.8%Sulfamethoxazole-Trimethoprim100%Part D≥11 patients+ 5 more classes in this area
Cardiovascular
11.6%Statin4.7%Rosuvastatin Calcium100%Part D<11 patientsCalcium channel blocker4.3%Amlodipine Besylate100%Part D<11 patients+ 1 more class in this area
Nervous system
7.5%Nonsteroidal Anti-inflammatory Drug5.1%Ibuprofen100%Part D<11 patientsAtypical Antipsychotic2.4%Quetiapine Fumarate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Case Series of People With HIV on the Long-Acting Combination of Lenacapavir and Cabotegravir: Call for a Trial
Open Forum Infectious Diseases
2024 - Real World Virologic Outcomes in Patients With Elevated Body Mass Index Receiving Long Acting Cabotegravir/Rilpivirine
Clinical Infectious Diseases
2024 - Case Series of People with HIV on the Long-Acting Combination of Lenacapavir and Cabotegravir
SSRN Electronic Journal
2023 - Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial
The Lancet Respiratory Medicine
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Mohamed Gad, MD, MPH
Hospital of the University of Pennsylvania
Lawrence Wechsler, MD
Hospital of the University of Pennsylvania
John Hirshfeld, MD
Hospital of the University of Pennsylvania
Noelle Frey, MD
Hospital of the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”